Betulinic acid is the lead compound among lupane-type pentacyclic triterpenoids and is interesting as a platform for developing drugs with antitumor, antiviral, antimicrobial, and other types of pharmacological activity [15]. Recently, a series of ionic betulinic-acid derivatives such as ammonium and triphenylphosphonium salts were synthesized. They exhibited significantly higher antitumor and antimicrobial activity than the acid itself [613]. Sulfobetaine derivatives of betulinic acid and other lupane-type pentacyclic triterpenoids have not been reported despite the frequent use of the biomimetic sulfobetaine group to design biologically active compounds with antibacterial, antiviral, and antiproliferative properties; to increase the solubility of hydrophobic compounds; and also to construct nanocarriers for targeted drug delivery [1421].

New derivatives of betulinic acid (1) were prepared and their structure–biological-activity relationship was studied using the synthetic method developed by us for betulinic-acid sulfobetaines 24, a new class of lupane-type pentacyclic triterpenoids containing N,N-(dimethylammonium)butane-1-sulfonate bonded to the C-3 or C-28 position of the triterpene backbone.

MediaObject ImageObject

Sulfobetaines 24 were prepared by treating the corresponding triterpene C-3 or C-28 tertiary amine of 5–7 with commercially available 1,4-butane sultone [22, 23]. Betulinic acid C-3 tertiary amine 5 was synthesized by acylating the C-3-OH of betulin 28-O-vinyl ether with chloroacetic acid (DCC, DMAP) and oxidizing in two steps the resulting betulin 3β-chloroacetate (9) with pyridinium chlorochromate (PCC) to give the corresponding aldehyde, which was reacted immediately after flash chromatography with NaClO2 to obtain the 3β-chloroacetate of acid 10. Amination of 10 with an excess of N,N-dimethylamine (40% aqueous) gave tertiary amine 5 in 93% yield. C-28-O-Vinyl ether 8, which was prepared by us earlier via vinylation of betulin with acetylene in KOH–DMSO superbase [24], turned out to be a convenient intermediate for synthesizing betulinic acid 3β-chloroacetate 10.

Protection of the primary hydroxyl in betulin by a vinyl group, its removal by treating the reaction mixture with HCl (10%), and subsequent purification of the product by flash chromatography gave the target compound in a satisfactory yield of 65% and was a good alternative to tetrahydropyranyl or dimethyl-t-butylsilyl protecting groups that are usually used for this [2529].

3β-(2-Dimethylamino)acetate 6 was prepared via O-chloroacylation of betulinic acid methyl ester 12 with chloroacetic acid (DCC, DMAP) followed by amination of the resulting chloroacetate 11 with N,N-dimethylamine. C-28-Tertiary amine 7 was synthesized via amination of bromomethylate 13 [8] analogously to that for amines 5 and 6.

Sulfobetaines 24 were obtained after refluxing the corresponding tertiary amines 57 with an excess of 1,4-butane sultone under Ar in anhydrous MeCN. The precipitate of sulfobetaine that formed during the reaction was filtered off, rinsed several times with MeCN, and dried in vacuo. The structures of 24 were confirmed by mass, PMR, and 13C NMR spectral data (Table 1).

Table 1 13C NMR Spectra of 24, 57, 911, and 13 (δ, ppm)*
MediaObject ImageObject

Experimental

IR spectra were recorded in mineral oil on a Prestige-21 IR spectrophotometer (Shimadzu). PMR and 13C NMR spectra were recorded on an Avance III pulsed spectrometer (Bruker) at operating frequency 500.13 MHz for 1H and 125.47 MHz for 13C using a Z-gradient PABBO probe at constant sample temperature 298 K or on an AM-300 spectrometer (Bruker) at operating frequency 300.13 and 75.47 MHz, respectively. Chemical shifts δ in PMR and 13C NMR spectra were measured in ppm vs. TMS internal standard. Spin–spin coupling constants were measured in Hz. PMR and 13C NMR spectra of 24 were assigned using standard 1D and 2D programs embedded in the Avance III spectrometer. Positive- and negative-ion mass spectra were recorded using electrospray ionization (ESI) on an LCMS-2010EV GC-MS (Shimadzu) (heater temperature 200°C, vaporizer temperature 230°C, sprayer flow rate 1.5 L/min, ion-source potential 3.5 kV, injected sample volume 2.5 μL, MeCN–H2O eluent). Rotation angles were measured on a PerkinElmer 341C instrument. Column chromatography used SiO2 (L grade, 40/60 μm, Russia). TLC was performed on Sorbfil plates (PTSKh-AF-A, ZAO Sorbpolimer, Krasnodar, Russia). Melting points were determined on a Kofler apparatus. Betulin was isolated from Betula pendula bark by the literature method [30]. Betulin O-vinyl ether 8 was prepared as before [24]; bromomethyl ester 13, by the literature method [8]; betulinic acid methyl ester, by the literature method [31]. Anhydrous MeCN was prepared by distillation over P2O5 and then over CaH2.

3 β -(2-Chloroacetoxy)-28-hydroxylup-20(29)-ene (9). A solution of vinyl ether 8 (0.78 g, 1.667 mmol) and chloroacetic acid (0.32 g, 3.333 mmol) in anhydrous CH2Cl2 (30 mL) was treated under Ar with DMAP (0.41 g, 3.333 mmol), stirred for 5 min, treated in one portion with DCC (0.69 g, 3.333 mmol), and stirred for 30 min. The precipitate of N,N-dicyclohexylurea was filtered off. The filtrate was washed with HCl (10%, 10 mL) and water and dried over Na2SO4.

The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (C6H6–MTBE, 4:1) to afford 9 (0.56 h, 65%) [32]. Amorphous, [α] 20D +4.8° (c 0.37, CHCl3). IR spectrum (ν, cm–1): 3400, 1758, 1645. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hzö): 0.79 (1H, d, J = 9.4, H-5), 0.84 (6H, s, CH3-24, 25), 0.86 (3H, s, CH3-23), 0.96 (3H, s, CH3-26), 1.01 (3H, s, CH3-27), 1.67 (3H, s, CH3-30), 1.80–2.00 (3H, m, Hb-16, 21, 22), 2.37 (1H, dt, J = 5.7, 11.0, H-19), 3.30 (1H, d, J = 10.8, Ha-28), 3.79 (1H, d, J = 10.8, Hb-28), 4.04 (2H, s, CH2Cl), 4.55 (1H, m, H-3), 4.57 (1H, s, Ha-29), 4.67 (1H, s, Hb-29). ESI-MS, m/z 425 [M – ClCH2CO2]+ (calcd 518 for C32H51ClO3).

3 β -(2-Chloroacetoxy)lup-20(29)-en-28-oic Acid (10). A solution of 9 (0.56 g, 1.088 mmol) in anhydrous CH2Cl2 (30 mL) was stirred under Ar, treated in one portion with PCC (0.70 g, 3.263 mmol), stirred for 1 h, diluted with MTBE (30 mL), stirred for 15 min, and filtered through a layer of Al2O3. The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (C6H6–MTBE, 4:1) to afford the aldehyde (0.56 g, 98%), which was dissolved in t-BuOH (33 mL), treated with 2-methyl-2-butene (0.5 mL) and then simultaneously dropwise with solutions of NaClO2 (0.74 g, 6.505 mmol) in H2O (5 mL) and NaH2PO4 (0.78 g, 6.505 mmol) in H2O (3 mL), stirred for 40 min, diluted with H2O (100 mL), and extracted with CHCl3 (5 × 30 mL). The organic layer was dried over Na2SO4. The solvent was evaporated. The residue was chromatographed over SiO2 (C6H6, C6H6–MTBE, 4:1) to afford 10 (0.40 g, 70%) [32]. Amorphous, [α] 20D +2.5° (c 0.6, CHCl3). IR spectrum (ν, cm–1): 1728 (C=C, C=O), 1693, 1638. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.79 (1H, d, J = 9.4, H-5), 0.85 (6H, s, CH3-24, 25), 0.86 (3H, s, H-23), 0.92 (3H, s, CH3-27), 0.96 (3H, s, CH3-26), 1.68 (3H, s, CH3-30), 1.96 (2H, m, Hb-21, 22), 2.17 (1H, t, J = 10.0, H-13), 2.27 (1H, d, J = 12.0, Hb-16), 3.02 (1H, dt, J = 5.5, 10.5, H-19), 4.05 (2H, s, CH2Cl), 4.54 (1H, dd, J = 6.4, 10.0, H-3), 4.61 (1H, s, Ha-29), 4.74 (1H, s, Hb-29). ESI-MS, m/z 531 [M – H]–(calcd 532 for C32H49ClO4).

Methyl 3 β -(2-Chloroacetoxy)lup-20(29)-en-28-oate (11). A solution of methyl ester 12 (0.50 g, 1.064 mmol) in anhydrous CH2Cl2 (60 mL) was treated with chloroacetic acid (0.20 g, 2.128 mmol) and DMAP (0.26 g, 2.128 mmol), stirred for 5 min, treated with DCC (0.44 g, 2.128 mmol), and stirred under Ar for 20 min. The precipitate of N,N-dicyclohexylurea was filtered off. The organic layer was washed with HCl (10%, 20 mL) and water and dried over Na2SO4. The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (C6H6–MTBE, 4:1) to afford 11 (0.55 g, 94%). Amorphous, [α] 20D 4° (c 0.15, CHCl3). IR spectrum (ν, cm–1): 1734, 1650. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.68 (1H, d, J = 10.0, H-5), 0.84 (3H, s, CH3-24), 0.85 (3H, s, CH3-25), 0.86 (3H, s, CH3-23), 0.91 (3H, s, CH3-27), 0.95 (3H, s, CH3-26), 1.68 (3H, s, CH3-30), 1.87 (2H, m, Hb-21, 22), 2.19 (1H, m, H-13), 2.22 (1H, m, Hb-16), 3.00 (1H, dt, J = 4.5, 11.0, H-19), 3.66 (3H, s, COOCH3), 4.05 (2H, s, CH2Cl), 4.56 (1H, dd, J = 6.0, 10.0, H-3), 4.60 (1H, s, Ha-29), 4.73 (1H, s, Hb-29). ESI-MS, m/z 453 [M – ClCH2CO2]+ (calcd 546 for C33H51ClO4).

3 β -[2-(Dimethylamino)acetoxy]lup-20(29)-en-28-oic Acid (5). A suspension of 10 (0.30 g, 0.498 mmol) in EtOH (15 mL) was treated with dimethylamine (0.6 mL, 4.975 mmol, 40% aq.) and refluxed for 4 h. The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (CHCl3–MeOH, 10:1) to afford 5 (0.25 g, 93%). Amorphous, [α] 20D +8.6° (c 0.33, CHCl3). IR spectrum (ν, cm–1): 3389, 1734, 1707, 1641. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.80 (1H, m, H-5), 0.82 (3H, s, CH3-24), 0.83 (3H, s, CH3-23), 0.85 (3H, s, CH3-25), 0.92 (3H, s, CH3-27), 0.97 (3H, s, CH3-26), 1.68 (3H, s, CH3-30), 1.90 (2H, m, Hb-21, 22), 2.21 (2H, m, H-13, Hb-16), 2.38 (6H, s, N(CH3)2), 2.98 (1H, dt, J = 5.6, 11.0, H-19), 3.21 (2H, s, OC(O)CH2N), 4.56 (1H, dd, J = 5.3, 11.0, H-3), 4.58 (1H, s, Ha-29), 4.71 (1H, s, Hb-29). ESI-MS, m/z 542 [M + H]+ (calcd 541 for C34H55NO4).

Methyl 3 β -[2-(Dimethylamino)acetoxy]lup-20(29)-en-28-oate (6). A solution of 11 (0.20 g, 0.338 mmol) in EtOH (10 mL) was treated with dimethylamine (1.0 mL, 3.384 mmol, 40% aq.) and stirred for 1 h at 20°C. The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (C6H6–MTBE, 4:1) to afford 6 (0.11 g, 60%) amine 6. Mp 147–148°C, [α] 20D + 4° (c 0.39, CHCl3). IR spectrum (ν, cm–1): 1732, 1708, 1641. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.83 (10H, s, H-5, CH3-23, 24, 25), 0.91 (3H, s, CH3-27), 0.95 (3H, s, CH3-26), 1.68 (3H, s, CH3-30), 1.88 (2H, m, Hb-21, 22), 2.22 (2H, m, H-13, Hb-16), 2.36 (6H, s, N(CH3)2), 2.97 (1H, dt, J = 5.3, 11.0, H-19), 3.16 (2H, s, OC(O)CH2N), 3.66 (3H, s, COOCH3), 4.57 (1H, dd, J = 5.3, 10.5, H-3), 4.59 (1H, s, Ha-29), 4.73 (1H, s, Hb-29). ESI-MS, m/z 556 [M + H]+ (calcd 555 for C35H57NO4).

2-Bromoethyl 3_-Hydroxylup-20(29)-en-28-oate (13). A suspension of 1 (1.0 g, 2.193 mmol) in anhydrous DMF (24 mL) under Ar was treated with calcined K2CO3 (0.30 g, 2.13 mmol), stirred for 20 min, treated dropwise with dibromoethane (0.2 mL, 2.193 mmol) in DMF (1 mL), and stirred at 20°C for 5 h. The K2CO3 was filtered off. The filtrate was evaporated. The residue was chromatographed over SiO2 (C6H6, C6H6–MTBE, 16:1) to afford 13 (0.57 g, 50%). Mp 182–183°C (lit. [8] 185°C (MeOH)). 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.68 (1H, d, J = 8.0, H-5), 0.75 (3H, s, CH3-24), 0.81 (3H, s, CH3-25), 0.91 (3H, s, CH3-26), 0.95 (6H, s, CH3-23, 27), 1.68 (3H, s, CH3-30), 1.92 (2H, m, Hb-21, 22), 2.17 (1H, dt, J = 5.5, 11.0, H-13), 2.29 (1H, dd, J = 8.8, 1.8, Hb-6), 3.01 (1H, dt, J = 5.5, 10.5, Hb-19), 3.18 (1H, dd, J = 5.2, 11.0, H-3), 3.53 (2H, t, J = 6.0, CH2Br), 4.39 (1H, dt, J = 15.0, 6.0, COOCH2: Ha), 4.41 (1H, dt, J = 15.0, 6.0, COOCH2: Hb), 4.60 (1H, s, Ha-29), 4.73 (1H, s, Hb-29).

2-(Dimethylamino)ethyl 3 β -Hydroxylup-20(29)-en-28-oate (7). A solution of 13 (0.26 g, 0.443 mmol) in EtOH (15 mL) was treated with dimethylamine (0.2 mL, 4.434 mmol, 40% aq.) and stirred for 1 h at 20°C. The solvent was evaporated. The residue was purified by flash chromatography over SiO2 (C6H6–MTBE, 4:1) to afford 7 (0.24 g, 98%). Mp 181–182°C, [α] 20D –2.4° (c 0.3, CHCl3). IR spectrum (ν, cm–1): 3440, 1726, 1650. 1H NMR spectrum (300 MHz, CDCl3, δ, ppm, J/Hz): 0.69 (1H, m, H-5), 0.75 (3H, s, CH3-24), 0.81 (3H, s, CH3-25), 0.91 (3H, s, CH3-26), 0.95 (6H, s, CH3-23, 27), 1.67 (3H, s, CH3-30), 1.91 (2H, m, Hb-21, 22), 2.23 (1H, m, Hb-6), 2.28 (7H, s, H-13, N(CH3)2), 2.56 (2H, t, J = 6, CH2N), 3.01 (1H, m, H-19), 3.17 (1H, dd, J = 5.2, 10.5, H-3), 4.20 (2H, m, COOCH2), 4.59 (1H, s, Ha-29), 4.72 (1H, s, Hb-29). ESI-MS, m/z 529 [M + H]+ (calcd 528 for C34H57NO3).

4-({2-[17 β -Carboxylup-20(29)-en-3 β -yloxy]-2-oxoethyl}dimethylammonium)butane-1-sulfonate (2). A suspension of 5 (0.10 g, 0.185 mmol) in anhydrous MeCN (3 mL) under Ar was treated dropwise with a solution of 1,4-butane sultone (0.17 mL, 1.661 mmol) in anhydrous MeCN (1.0 mL) (three equal portions every hour), and refluxed for 30 h. The precipitate of 5 was filtered off, rinsed with MeCN (5 × 5 mL), and dried in vacuo (KOH, 80°C) to afford 2 (0.06 g, 48%, white powder). Mp 288–290°C, [α] 20D +11° (c 0.31, HCOOH). IR spectrum (ν, cm–1): 3440, 1743, 1725, 1640, 1204, 1193, 1151, 1307, 794. 1H NMR spectrum (500 MHz, CD3COOD, δ, ppm, J/Hz): 0.86 (1H, m, H-5), 0.89 (3H, s, CH3-24), 0.91 (6H, s, CH3-23, 25), 0.99 (3H, s, CH3-26), 1.04 (3CH, s, CH3-27), 1.06 (1H, m, Ha-1), 1.10 (1H, m, Ha-12), 1.20 (1H, d, J = 12.0, Ha-15), 1.31 (1H, m, Ha-11), 1.40 (1H, m, H-9), 1.42 (1H, m, Ha-21), 1.45 (2H, m, 2H-7), 1.48 (3H, m, Ha-6, Hb-11, Ha-16), 1.51 (1H, m, Ha-22), 1.56 (2H, m, Hb-6, 15), 1.65 (1H, m, H-18), 1.72 (5H, s, 2H-2, CH3-30), 1.75 (2H, m, Hb-1, 12), 1.90 (2H, m, NCH2CH2CH 2CH2SO3), 2.00 (2H, m, Hb-21, 22), 2.07 (2H, m, NCH2CH 2CH 2 CH2SO3), 2.30 (2H, m, H-13, Hb-16), 3.06 (3H, m, H-19, NCH2CH2CH2CH 2SO3), 3.37 (6H, s, N(CH3)2), 3.65 (2H, m, NCH 2CH2CH2CH2SO3), 4.36 (1H, d, J = 17.0, OC(O)CH2N: Ha), 4.42 (1H, d, J = 17.0, OC(O)CH2N: Hb), 4.63 (1H, s, Ha-29), 4.68 (1H, dd, J = 5.3, 10.5, H-3), 4.77 (1H, s, Hb-29). ESI-MS, m/z 678 [M + H]+ (calcd 677 for C38H63NO7S).

4-({2-[17 β -Methoxycarbonyllup-20(29)-en-3 β -yloxy]-2-oxoethyl}dimethylammonium)butane-1-sulfonate (3) was prepared analogously to 2 from 6 (0.11 g, 0.202 mmol) and 1,4-butane sultone (0.20 mL, 2.02 mmol). Yield 0.054 g (39%) (white powder). Mp 283–286°C, [α] 20D +13° (c 0.28, HCOOH). IR spectrum (ν, cm–1): 1729, 1650, 1203, 1166, 1136, 1040. 1H NMR spectrum (500 MHz, CD3CO2D, δ, ppm, J/Hz): 0.86 (1H, d, J = 10, H-5), 0.88 (3H, s, CH3-24), 0.90 (6H, s, CH3-23, 25), 0.95 (3H, s, CH3-26), 1.02 (3H, s, CH3-27), 1.05 (1H, m, Ha-1), 1.10 (1H, m, Ha-12), 1.20 (1H, m, Ha-15), 1.30 (1H, m, Ha-11), 1.39 (2H, m, H-9, Ha-21), 1.45 (7H, m, Ha-6, 2H-7, Hb-11, Hb-15, Ha-16, Ha-22), 1.52 (1H, m, Hb-6), 1.65 (1H, m, H-18), 1.71 (3H, s, CH3-30), 1.73 (4H, m, Hb-1, 2H-2, Hb-12), 1.90 (4H, m, NCH2CH2CH 2CH2SO3, Hb-21, 22), 2.06 (2H, m, NCH2CH 2CH2CH2SO3), 2.24 (2H, m, H-13, Hb-16), 3.03 (3H, m, H-19, NCH2CH2CH2CH 2SO3), 3.34 (6H, s, N(CH3)2), 3.64 (2H, m, NCH 2CH2CH2CH2SO3), 3.68 (3H, s, COOCH3), 4.36 (1H, d, J = 17.0, OC(O)CH2N: Ha), 4.39 (1H, d, J = 17.0, OC(O)CH2N: Hb), 4.61 (1H, s, Ha-29), 4.66 (1H, dd, J = 5.3, 10.5, H-3), 4.73 (1H, s, Hb-29). ESI-MS, m/z 714 [M + Na]+ (calcd 691 for C39H65NO7S).

4-({2-[3 β -Hydroxylup-20(29)-en-17 β -carbonyloxy]ethyl}dimethylammonium)butane-1-sulfonate (4) was prepared analogously to 2 from 7 (0.12 g, 0.224 mmol) and 1,4-butane sultone (0.20 mL, 2.02 mmol). Yield 0.04 g (27%) (white powder). Mp 265–267°C, [α] 20D +9.5° (c 0.4, HCOOH). IR spectrum (ν, cm–1): 3414, 1726, 1650, 1212, 1166, 1037, 1036. 1H NMR spectrum (500 MHz, CD3CO2D, δ, ppm, J/Hz): 0.68 (1H, d, J = 10.0, H-5), 0.78 (3H, s, CH3-24), 0.86 (3H, s, CH3-25), 0.95 (4H, s, CH3-26, m, Ha-1), 0.96 (3H, s, CH3-23), 1.02 (3H, s, CH3-27), 1.08 (1H, m, Ha-12), 1.25 (2H, m, Ha-11, 15), 1.40 (1H, m, H-9), 1.43 (6H, m, Ha-6, 2H-7, Hb-15, Hb-11, Ha-21), 1.54 (3H, m, Hb-6, Ha-16, Ha-22), 1.65 (1H, m, H-18), 1.68 (2H, m, H-2), 1.70 (4H, m, Hb-1, s, CH3-30), 1.74 (1H, m, Hb-12), 1.92 (4H, m, Hb-21, 22, NCH2CH 2CH2CH2SO3), 2.05 (2H, m, NCH2CH2CH 2CH2SO3), 2.23 (1H, d, J = 13.7, Hb-16), 2.28 (1H, dt, J = 3.5, 12.5, H-13), 3.02 (1H, dt, J = 5.5, 11.5, H-19), 3.07 (2H, t, J = 7.5, NCH2CH2CH2CH 2SO3), 3.23 (6H, s, N(CH3)2), 3.26 (1H, dd, J = 5.5, 10.5, H-3), 3.54 (2H, m, NCH 2CH2CH2CH2SO), 3.78 (2H, br.s, C(O)OCH2CH2N), 4.59 (1H, d, J = 14.0, C(O)OCH2CH2N: Ha), 4.63 (1H, s, Ha-29), 4.65 (1H, d, J = 14.0, C(O)OCH2CH2N: Hb), 4.76 (1H, s, Hb-29). ESI-MS, m/z 664 [M + H]+ (calcd 663 for C38H65NO6S).